MedTrace Logo

BioCleanse Tibialis Tendon Anterior Cruciate Ligament (ACL) Study

NCT00975845 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2021-11-01

No results posted yet for this study

Summary

To compare the outcome of Anterior Cruciate Ligament (ACL) reconstruction performed using the tibialis allograft to historical outcomes of ACL reconstruction patients and to establish if any correlation exists between the age of the graft donor and the clinical outcomes.

Conditions

  • Anterior Cruciate Ligament Rupture

Interventions

OTHER

BioCleanse Tibialis tendon

Outcomes of anterior cruciate replacement will be evaluated

Sponsors & Collaborators

  • RTI Surgical

    lead INDUSTRY

Principal Investigators

  • Thomas Carter, MD · Foundation for Orthopedic Research and Education

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-09
Primary Completion
2017-11-09
Completion
2017-11-09

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00975845 on ClinicalTrials.gov